276 related articles for article (PubMed ID: 16931107)
41. [Cytokines in health and disease].
Fireman L; Qivity S
Harefuah; 1996 Aug; 131(3-4):107-11. PubMed ID: 8854496
[No Abstract] [Full Text] [Related]
42. Cytokines in dermatology.
Holman DM; Kalaaji AN
J Drugs Dermatol; 2006 Jun; 5(6):520-4. PubMed ID: 16774103
[TBL] [Abstract][Full Text] [Related]
43. [Cytokines and solid tumors].
Triebel F; Escudier B
Rev Prat; 1993 Mar; 43(5):580-5. PubMed ID: 7688136
[TBL] [Abstract][Full Text] [Related]
44. Cytokines: their role in uveal disease.
Kijlstra A
Eye (Lond); 1997; 11 ( Pt 2)():200-5. PubMed ID: 9349412
[No Abstract] [Full Text] [Related]
45. Cytokines: interleukin and interferon therapy in dermatology.
Asadullah K; Sterry W; Trefzer U
Clin Exp Dermatol; 2002 Oct; 27(7):578-84. PubMed ID: 12464153
[TBL] [Abstract][Full Text] [Related]
46. The role of biotherapies (interleukins, interferons and erythropoietin) in multiple myeloma.
Avvisati G; Petrucci MT; Mandelli F
Baillieres Clin Haematol; 1995 Dec; 8(4):815-29. PubMed ID: 8845574
[TBL] [Abstract][Full Text] [Related]
47. Cytokines and immunological monitoring.
Kopp WC; Holmlund JT
Cancer Chemother Biol Response Modif; 1996; 16():189-238. PubMed ID: 8639383
[No Abstract] [Full Text] [Related]
48. Antitumour actions of interferons: implications for cancer therapy.
Parker BS; Rautela J; Hertzog PJ
Nat Rev Cancer; 2016 Mar; 16(3):131-44. PubMed ID: 26911188
[TBL] [Abstract][Full Text] [Related]
49. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review).
Rao VS; Dyer CE; Jameel JK; Drew PJ; Greenman J
Oncol Rep; 2006 Jan; 15(1):179-85. PubMed ID: 16328053
[TBL] [Abstract][Full Text] [Related]
50. [Cytokines in clinical medicine].
Nordstedt C; Kvanta A; Holm G
Lakartidningen; 1989 Mar; 86(10):834, 836, 838. PubMed ID: 2466182
[No Abstract] [Full Text] [Related]
51. The cytokines: a review of interleukins.
Weber RL; Iacono VJ
Periodontal Clin Investig; 1997; 19(1):17-22. PubMed ID: 9495930
[TBL] [Abstract][Full Text] [Related]
52. Effects of interferons and other cytokines on tumors in animals: a review.
Thomas H; Balkwill FR
Pharmacol Ther; 1991 Dec; 52(3):307-30. PubMed ID: 1726476
[TBL] [Abstract][Full Text] [Related]
53. Immunotherapy for breast cancer.
Knutson KL; Bishop MR; Schiffman K; Disis ML
Cancer Chemother Biol Response Modif; 2002; 20():351-69. PubMed ID: 12703214
[No Abstract] [Full Text] [Related]
54. [Interferons as antineoplastic drugs--direct regulatory effects on tumor cells].
Kubes M
Bratisl Lek Listy; 1993 Nov; 94(11):596-601. PubMed ID: 7522936
[TBL] [Abstract][Full Text] [Related]
55. Scleroderma and malignancy. Mechanisms of interrelationship.
Wenzel J
Eur J Dermatol; 2002; 12(3):296-300. PubMed ID: 11978579
[TBL] [Abstract][Full Text] [Related]
56. [Roles of cytokines in the lipid metabolism].
Kawakami M
Nihon Rinsho; 2001 Feb; 59 Suppl 2():426-31. PubMed ID: 11351623
[No Abstract] [Full Text] [Related]
57. Interferon treatment in immunosuppressed patients.
Khan A; Hill NO
Ann Allergy; 1980 May; 44(5):289. PubMed ID: 6155096
[No Abstract] [Full Text] [Related]
58. Cytokines as Mediators of Pain-Related Process in Breast Cancer.
Panis C; Pavanelli WR
Mediators Inflamm; 2015; 2015():129034. PubMed ID: 26635447
[TBL] [Abstract][Full Text] [Related]
59. IL-24: a classic cytokine and/or a potential cure for cancer?
Kreis S; Philippidou D; Margue C; Behrmann I
J Cell Mol Med; 2008 Dec; 12(6A):2505-10. PubMed ID: 18505472
[TBL] [Abstract][Full Text] [Related]
60. New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27.
Murakami M; Kamimura D; Hirano T
Growth Factors; 2004 Jun; 22(2):75-7. PubMed ID: 15253382
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
